KPMA proposes to institutionalize ex post facto drug management rules

The Korea Pharmaceutical Manufacturers Association (KPMA) said it would propose its ex post facto drug management rules to the government, to this effect that the minimum drug-pricing system should be applied to the direct transaction of pharmaceutical firms, while pharmaceutical firms suffer minimal disadvantage from subsequent reductions in insurance drug prices by expanding the types of abno...